Novel Homozygous Pathogenic Variant in DNAJC6 Causes Rapid Progressive Parkinsonism
- 7 July 2026
- journal article
- review article
- Published by Wiley in Movement Disorders Clinical Practice
Abstract
Background: Biallelic variants in DNAJC6 cause PARK‐ DNAJC6 (historically referred to as PARK19), a rare autosomal recessive juvenile‐onset dystonia‐parkinsonism syndrome. Neurodevelopmental delay or regression, epilepsy, movement disorders, and psychiatric symptoms are also present. Progression is fast with frequent bulbar, gastrointestinal involvement and early loss of ambulation. Cases: We report two siblings (17 and 14 years) harboring a novel homozygous nonsense variant in DNAJC6 , p.Cys325*, not previously described in the medical literature and absent from population databases. The variant is predicted to truncate the protein, supporting a loss‐of‐function mechanism consistent with the gene's disease biology. Both patients exhibited developmental regression, parkinsonism with dystonia, cognitive decline, dysphagia, and marked sialorrhea, with severe, accelerated functional deterioration. Levodopa produced only mild benefit; in the older sibling, dose escalation provoked an adverse reaction with sustained upgaze/ophthalmoparesis, opisthotonus, and hypertension. Literature review: We found 23 previously reported DNAJC6 patients, most with early‐onset parkinsonism with variable levodopa responsiveness, frequent developmental and psychiatric comorbidity, and prominent bulbar features. Conclusions: The novel DNAJC6 p.Cys325* variant is associated with severe, early‐onset parkinsonism and developmental regression. DNAJC6 should be considered in children and adolescents presenting with parkinsonism plus neurodevelopmental decline, particularly when levodopa benefit is modest, and dose‐related adverse motor crises occur.Keywords
This publication has 19 references indexed in Scilit:
- Homozygous DNAJC6 Mutated Juvenile Onset Dystonia‐Parkinsonism Is Responsive to Pallidal Deep Brain StimulationMovement Disorders Clinical Practice, 2024
- X‐Linked Levodopa‐Responsive Parkinsonism‐Epilepsy Syndrome: A Novel PGK1 Mutation and Literature ReviewMovement Disorders Clinical Practice, 2024
- Mouse models for inherited monoamine neurotransmitter disordersJournal of Inherited Metabolic Disease, 2024
- Juvenile Dystonia‐Parkinsonism Due to DNAJC6 MutationMovement Disorders Clinical Practice, 2021
- Mutation Analysis of DNAJC Family for Early‐Onset Parkinson's Disease in a Chinese CohortMovement Disorders, 2020
- DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism‐DystoniaMovement Disorders, 2020
- Auxilin Underlies Progressive Locomotor Deficits and Dopaminergic Neuron Loss in a Drosophila Model of Parkinson’s DiseaseCell Reports, 2017
- A Novel Nonsense Mutation in DNAJC6Expands the Phenotype of Autosomal‐Recessive Juvenile‐Onset Parkinson's DiseaseAnnals of Neurology, 2015
- DNAJC6Mutations Associated With Early‐Onset Parkinson's DiseaseAnnals of Neurology, 2015
- DNAJC6 is responsible for juvenile parkinsonism with phenotypic variabilityParkinsonism & Related Disorders, 2013